Didier Argentin
Business Development Sr Director, Europe
Quantoom Biosciences
Nivelles, Belgium
Since 2021, I am the head of BD Europe of Quantoom Biosciences, where I acquired a strong expertise in the field of m/saRNA manufacturing processes & nanoparticles.
My organisation
About me
25 years expertise in leading the business development of bioproduction companies :
@ Former CBO of Henogen/Novasep CDMO ( currently the Belgian manufacturing site of Thermo-Fischer, for viral vectors) : 2002-2011
@ Didier has also been the former CBO, cofounder and board member of MasTherCell, CDMO for cell therapeutics (acquired by Catalent in Feb 2020 for $315M) : 2011-2014
@ as well as the founder and CEO of SynAbs : CRDO for monoclonal antibodies for the IVD market : 2014-2020
@ Since 2021, He is the current head of BD Europe of Quantoom Biosciences, where he acquired a very strong expertise in the field of mRNA and saRNA manufacturing processes, nanoparticles and analyticals; Didier also participated in 2023 to the implementation and starting mRNA operations and business at ExoThera CDMO, as well as Samabriva 3M€ funding as board member.
Additional questions
Interests
What is your primary goal for attending this event?